Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Atrial Fibrillation
Location: United States, CA
RESCUE cardiovascular clinical trial
A diagnostic tool for angina symptoms will be associated with no increase in MACE or revascularization, decreased, cost, reduce risks (less radiation exposure), additional insights into alternate explanations of chest pain, and increased cost effectiveness in comparison with use of SPECT MPI.
Patient Inclusion Criteria:
Able to consent, 40 years of age or older, presentation with symptoms of unstable angina (CCS class I to III) or angina equivalent with or without known CAD. Planned non invasive imaging for CAD diagnosis, able to tolerate CCTA (coronary computed tomography angiography) or SPECT MPI per randomization as required by protocol.
Patient Exclusion Criteria:
Prior revascularization, renal insufficiency or failure, history of allergy like reaction to iodinated contrast, atrial fibrillation or significant arrhythmia judged to potentially limit quality of CCTA, acute ischemia, acute myocardial infarction, severe myocardial ischemia.
Nasra Hashmi, Research Specialist
Coastal Multi-Specialty Research
2621 S. Bristol Street
Santa Ana, CA 92704
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these